CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers When, where, and how to target vascular inflammation in the post-CANTOS era? Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial Association Between Depressive Symptoms and Incident Cardiovascular Diseases A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy after Implantation of Drug-eluting Stents Guided by either Intravascular Ultrasound or Angiography in Patients with Acute Coronary Syndrome: Rationale and Design of Prospective, Multicenter, Randomized, Controlled IVUS-ACS & ULTIMATE-DAPT trial Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic Stenosis Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)

LetterVolume 12, Issue 8, April 2019

JOURNAL:JACC Cardiovasc Interv. Article Link

Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?

Yaylali YT, Basarici I. Keywords: pulmonary artery denervation; pulmonary hypertension

LINK

Please click on the "Article Link" on top right to get further access to this Letter.